Bangladesh has produced Remdesivir, a drug which is recognised as very effective for the treatment of coronavirus.
Eskayef Pharmaceuticals Ltd, also known as SKF, the country’s one of the leading drug manufacturing company, is preparing for the distribution of the drug after its successful production.
Directorate General of Drug Administration (DGDA) has said the drug will be delivered to hospitals after its final performance test.
SKF is the first pharmaceutical company in the world to produce generic group Remdesivir. The brand name of the SKF produced Remdesivir is Remivir.
According to rules, the samples will be submitted to the Bangladesh National Control Laboratory for medicinal products (NCL) under the DGDA, and distribution will start as soon as clearance and marketing permission are obtained, SKF said.
The company also said they made a deal with the main producer of the drug and US company Gilead Sciences Inc, and they have adequate raw materials for producing the drug.
SKF's Director of Marketing and Sales Dr. Mujahidul Islam said they have completed all the steps of manufacturing the world’s first Remdesivir. “We’ll be able to deliver the drugs to the hospital just on completion of a process.
The DGDA said they will allow the use of the drug after its final performance test.
Major General Mahbubur Rahman, Director General of the DGDA, said the government and the DGDA have been working together to bring the drug in the market.
“It’s revolutionary incident that Bangladesh is producing such a drug.”
In addition to SKF, the DGDA has allowed eight other pharmaceutical companies, including Beximco, Beacon Incepta and Square, to produce the drug.